Assessment of the Role of Renal Organic Anion Transporters in Drug-Induced Nephrotoxicity

Antibiotics for the treatment of dysentery in children

(2010) B. S. Traa et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Pharmacokinetics of Ceftriaxione, a Third-Generation Cephalosporin, in Pediatric Patients

(2009) Kyoko Fukumoto et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Renal Vulnerability to Drug Toxicity

(2009) M. A. Perazella   Clinical Journal of the American Society of Nephrology

Carnitine/Organic Cation Transporter OCTN2 (Slc22a5) Is Responsible for Renal Secretion of Cephaloridine in Mice

(2009) T. Kano et al.   DRUG METABOLISM AND DISPOSITION

Interstitielle Nephritis

(2009) J. Halbritter et al.   INTERNIST

Molecular evidence for an involvement of organic anion transporters (OATs) in aristolochic acid nephropathy

(2009) Nadiya Bakhiya et al.   TOXICOLOGY

Differentiation-dependent regulation of the intestinal folate uptake process: studies with Caco-2 cells and native mouse intestine

(2008) Veedamali S. Subramanian et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Novel Nucleotide Human Immunodeficiency Virus Reverse Transcriptase Inhibitor GS-9148 with a Low Nephrotoxic Potential: Characterization of Renal Transport and Accumulation

(2008) T. Cihlar et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Protective effect of morin on the imipenem-induced nephrotoxicity in rabbits

(2008) Sung-Chul Lim et al.   ARCHIVES OF PHARMACAL RESEARCH

Involvement of Multidrug Resistance-Associated Protein 2 (Abcc2) in Molecular Weight-Dependent Biliary Excretion of  -Lactam Antibiotics

(2008) Y. Kato et al.   DRUG METABOLISM AND DISPOSITION

The Carnitine Transporter SLC22A5 Is Not a General Drug Transporter, but It Efficiently Translocates Mildronate

(2008) S. Grigat et al.   DRUG METABOLISM AND DISPOSITION

Safety of ceftriaxone sodium at extremes of age

(2008) Scott V Monte et al.   Expert Opinion On Drug Safety

Drug-induced crystal nephropathy: an update

(2008) Sri G Yarlagadda et al.   Expert Opinion On Drug Safety

Functional Characterization of Multidrug and Toxin Extrusion Protein 1 as a Facilitative Transporter for Fluoroquinolones

(2008) K.-y. Ohta et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Aristolochic acid nephropathy: A worldwide problem

(2008) Frédéric D. Debelle et al.   KIDNEY INTERNATIONAL

The Proton-Coupled Folate Transporter: Impact on Pemetrexed Transport and on Antifolates Activities Compared with the Reduced Folate Carrier

(2008) R. Zhao et al.   MOLECULAR PHARMACOLOGY

Organic Anion Transporter 3 (Oat3/Slc22a8) Interacts with Carboxyfluoroquinolones, and Deletion Increases Systemic Exposure to Ciprofloxacin

(2008) A. L. VanWert et al.   MOLECULAR PHARMACOLOGY

Physiological and pharmacokinetic roles of H+/organic cation antiporters (MATE/SLC47A)

(2007) Tomohiro Terada et al.   BIOCHEMICAL PHARMACOLOGY

Aristolochic acid induces proximal tubule apoptosis and epithelial to mesenchymal transformation

(2007) A.A. Pozdzik et al.   KIDNEY INTERNATIONAL